Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Bimatoprost 0.03% discontinued

The manufacturer of bimatoprost (Lumigan®) has discontinued the 0.3mg/ml or 0.03% strength of this product in dropped bottles, the 0.01% product and the unit dose version are not affected and remain available.

According to an Assessment Report at the European Medicines agency the lower strength product is a direct equivalent. The report states, "Compared with the current authorised strength which contains 0.3 mg/ml bimatoprost and 50 ppm benzalkonium chloride, the new strength contains a third of the concentration of bimatoprost (0.1 mg/ml) and 200 ppm benzalkonium chloride. The higher concentration of benzalkonium chloride increases the ocular absorption of bimatoprost thus allowing for a lower concentration of bimatoprost to be administered (0.1 mg/ml). This new formulation, with a reduced concentration of bimatoprost, achieves comparable IOP-lowering efficacy to the current authorised strength and an improved overall safety profile.

There is a cost difference between the two strengths with the 0.03% strength currently priced at £10.30 for 3ml and the 0.01% strength currently more expensive at £11.71 for 3ml.

Action: Clinicians should be aware of this product being discontinued. It may be prudent to run clinical system searches to identify any patients who are currently prescribed this product to allow a review and an alternative to be arranged.

Share 'Bimatoprost 0.03% discontinued' on Email Share 'Bimatoprost 0.03% discontinued' on Delicious Share 'Bimatoprost 0.03% discontinued' on Digg Share 'Bimatoprost 0.03% discontinued' on Facebook Share 'Bimatoprost 0.03% discontinued' on reddit Share 'Bimatoprost 0.03% discontinued' on Twitter

atomic-wealth

36 Comments to “Bimatoprost 0.03% discontinued”

  1. I have a bottle of 0.03% drops. I am using an extremely fine brush to apply the drop solution to my eyelids as a Latisse substitute. Any problem with thus application?

    Comment by Patricia — May 1, 2020 #
    Reply

    1. @Patricia,

      That's fine, it's a different product for a different problem - Latisse is used to promote eye lash growth, not for raised intra-ocular eye pressure. In the UK it is private as it is for a cosmetic, rather than medical purpose.

      Comment by Matthew Robinson — May 2, 2020 #
      Reply

  2. I have been using Lumigan 0.03% for glaucoma/high eye pressure for 12 years now with no problems, itchy eyes sometimes.

    Comment by Garry — March 15, 2020 #
    Reply

  3. I have just been given this drop from a cosmetic salon for eye lash growth. Luminance 0.3ml. Having just read it has been discontinued and not licensed for the UK, should I be concerned?

    Comment by Toni — August 6, 2019 #
    Reply

    1. @Toni,

      This medication has never been licensed for this use in the UK, but it is licensed for that use in America. As far as I'm aware it is a prescription only medicine in the UK so the legality of the supply made to you is questionable.

      Comment by Matthew Robinson — August 6, 2019 #
      Reply

  4. With Lumigan I had brown staining around my eyes then redness and eyes "popping out of my head" followed by extreme pain in the head, the face and the mouth. Once I stopped Lumigan these symptoms disappeared very quickly.

    Comment by L. During — May 8, 2019 #
    Reply

  5. Can I apply this to grow eyebrows?

    Comment by Eyebrows — March 30, 2019 #
    Reply

    1. @Eyebrows,

      Eye lash growth is a very common side effect of this drop when use for raised eye pressure. I believe there is a licensed for this use in America but it is unlicensed for this purpose in the UK.

      Comment by Matthew Robinson — March 30, 2019 #
      Reply

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer